NCT00866619: Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa
- State
- Completed
- Phase
- Phase 3
- People
- 15,459 taking part
- Started
- 27 Mar 2009
- Primary completion
- 1 Mar 2011
- Arms
- GSK257049 [6-12W] Group
- Results
- Posted on the registry
- 20 Mar 2009: Trial registered
- 27 Mar 2009: Trial started
- 31 Jan 2014: Trial completed
- 9 Oct 2019: Trial results posted